Bull case
BUD would need investors to value it at roughly 56x earnings — about 38x more generous than today's 18x forward P/E. That requires meaningful multiple expansion on top of continued earnings growth.
Wall Street verdict, consensus price target, and analyst rating breakdown — everything needed to frame the risk/reward at today's price.
Three scenarios for where BUD stock could go
BUD would need investors to value it at roughly 56x earnings — about 38x more generous than today's 18x forward P/E. That requires meaningful multiple expansion on top of continued earnings growth.
At 42x on FY1 earnings, the base case reflects a reasonable but not stretched valuation. It prices in continued growth without assuming an exceptional setup.
The bear case assumes sentiment or fundamentals disappoint enough to push BUD down roughly 45% from the current price.
Not financial advice. Model confidence reflects internal scenario assumptions, not a guarantee of returns. Past performance does not predict future results.

Anheuser-Busch InBev is the world's largest brewer, producing and distributing a global portfolio of beer brands. It generates revenue primarily from beer sales — with its largest markets being North America, Latin America, and Europe — and makes money through volume sales of its core brands like Budweiser, Corona, and Stella Artois. The company's competitive advantage lies in its massive global scale, extensive distribution network, and portfolio of iconic brands that command pricing power.
Quarterly beat-or-miss track record against analyst estimates, plus forward revenue and EPS outlook for the next two fiscal years.
| Quarter | EPS (Actual / Est) | EPS Surprise | Revenue (Actual / Est) | Rev Surprise |
|---|---|---|---|---|
| Q3 2025 | $0.98/$0.94 | +4.3% | —/$15.7B | — |
| Q4 2025 | $0.99/$0.97 | +2.1% | $30.0B/$15.6B | +92.4% |
| Q1 2026 | $0.95/$0.91 | +4.4% | $29.5B/$14.7B | +100.8% |
| Q2 2026 | $0.97/$0.90 | +7.8% | $30.6B/$14.7B | +108.4% |
BUD beat EPS estimates in 4 of 4 tracked quarters. A perfect track record raises the bar for the upcoming report.
Product and geographic revenue mix from the latest annual disclosure, with year-over-year growth by segment.
Latest annual revenue by segment or product family
Latest annual revenue by reported region
Tap, hover, or focus a slice to inspect segment detail.
Current multiples compared to the S&P 500, the company's sector, and its own five-year average.
Fair value est. $40 — implies -50.3% from today's price.
| Metric | BUD | S&P 500 | Consumer Defensive | 5Y Avg BUD |
|---|---|---|---|---|
| Forward PE | 18.4x | 18.8x | 14.2x+30% | — |
| Trailing PE | 28.2x | 24.4x+15% | 18.9x+49% | 37.9x-25% |
| PEG Ratio | — | 1.66x | 1.92x | — |
| EV/EBITDA | 9.5x | 15.2x-37% | 11.1x-14% | 10.8x-12% |
| Price/FCF | 12.4x | 20.7x-40% | 15.3x-19% | 14.6x-15% |
| Price/Sales | 2.3x | 3.1x-25% | 0.9x+164% | 2.3x |
| Dividend Yield | 1.62% | 1.91% | 3.06% | 2.01% |
Forward P/E and PEG reflect analyst consensus estimates. Historical averages use trailing ratios where forward data is unavailable.S&P 500 and sector benchmarks both use trailing median P/E — similar readings indicate the broader index and sector are priced alike.
Open valuation toolBUD generates $32.2B in free cash flow at a 26.9% margin — returns 2.3% of market cap to shareholders annually.
Revenue, margins, and cash generation
ROIC, leverage, and debt serviceability
~1.9 years to full repayment at current FCF run-rate
How capital is returned to owners
All figures from the trailing twelve months. ROIC uses invested capital (equity + net debt).
Open full ratios pageKey factors that could pressure the stock price, compress the multiple, or weigh on future results.
AI analysis · updated June 17, 2026
Downside risk is driven by declining sales volumes, which could negatively impact revenue and profitability.
Rising costs of raw materials and production inputs may squeeze margins and reduce earnings.
Potential challenges in refinancing debt could strain liquidity and increase financial instability.
Upside depends on margin recovery, which remains uncertain given current market conditions.
Sustained pricing power is required for upside, but competitive pressures may limit this ability.
Ineffective capital allocation decisions could hinder growth and shareholder returns.
These are risk mechanisms, not predictions. The key question is which would force a cut to earnings estimates or a lower multiple than the market currently prices in.
Structural drivers behind the upside case and why the stock could outperform over the next 12 months.
AI analysis · updated June 17, 2026
Comprehensive stock analysis, price targets, and dividend information are readily available for informed investment decisions.
Investors have access to real-time price charts, key statistics, and historical performance data.
Detailed revenue and earnings estimates from analysts provide insights into future performance.
MarketBeat offers up-to-date headlines, short interest data, and stock recommendations.
Vital stock trading and investing information helps investors evaluate opportunities.
A real bull case compounds — each driver matters most when it strengthens margins, supports capital returns, and keeps the company above the market's minimum growth bar simultaneously.
52-week range context and price returns across multiple time horizons. Dividend contribution is shown separately in the Capital Return section.
Range context matters because valuation compression and earnings misses rarely hit from the same starting point. A stock already far below its high can still fall, but it is no longer carrying the same embedded optimism as one pressing a fresh peak.
Valuation, growth, and margin comparison against the closest publicly traded peers for this company.
| Company | Mkt Cap | Fwd PE | Rev Grw | Margin | Rating | Upside |
|---|---|---|---|---|---|---|
BUD BUD Anheuser-Busch InBev SA/NV | $138.9B | 18.4x | +2.7% | 10.5% | Buy | +10.2% |
TAP TAP Molson Coors Beverage Company | $7.4B | 8.3x | +0.7% | -18.9% | Hold | +19.3% |
SAM SAM The Boston Beer Company, Inc. | $1.9B | 18.5x | +3.4% | -2.9% | Hold | +37.6% |
ABE ABEV Ambev S.A. | $48.7B | 2.9x | +6.3% | 17.7% | Hold | +2.6% |
STZ STZ Constellation Brands, Inc. | $24.5B | 12.0x | +3.9% | 11.8% | Buy | +26.2% |
DEO DEO Diageo plc | $44.7B | 17.1x | +2.7% | 14.7% | Hold | +38.6% |
This peer comparison reflects companies with similar business models, product lines, or market positioning, supplemented by industry grouping when direct matches are limited.
BUD returns 2.3% total yield, led by a 1.62% dividend. Buybacks add another 0.7%.
Yield, cadence, and growth quality
How much per-share support comes from repurchases
| Year | Div / Share | YoY Grw | BB Yield | Total Yield |
|---|---|---|---|---|
| 2026 | $1.17 | — | — | — |
| 2025 | $1.30 | +47.8% | — | — |
| 2024 | $0.88 | +6.8% | 0.9% | 3.5% |
| 2023 | $0.82 | +51.8% | 0.3% | 2.5% |
| 2022 | $0.54 | -8.9% | 0.0% | 2.0% |
Common questions answered from live analyst data and company financials.
Anheuser-Busch InBev SA/NV (BUD) is rated Buy by Wall Street analysts as of 2026. Of 45 analysts covering the stock, 26 rate it Buy or Strong Buy, 16 rate it Hold, and 3 rate it Sell or Strong Sell. The consensus 12-month price target is $89, implying +10.2% from the current price of $81. The bear case scenario is $117 and the bull case is $246.
The Wall Street consensus price target for BUD is $89 based on 45 analyst estimates. The high-end target is $100 (+23.9% from today), and the low-end target is $82 (+1.6%). The base case model target is $186.
BUD trades at 18.4x times forward earnings. The stock trades at a notable premium to the broad market, which is typical for businesses with strong free cash flow and above-average growth expectations. Based on current multiples versus the peer group, the relative model signals expensive versus peers. Whether the stock is over or undervalued ultimately depends on whether consensus earnings estimates are achievable.
The primary risks for BUD in 2026 are: (1) Volume Weakness — Downside risk is driven by declining sales volumes, which could negatively impact revenue and profitability. (2) Input-Cost Pressure — Rising costs of raw materials and production inputs may squeeze margins and reduce earnings. (3) Refinancing Risk — Potential challenges in refinancing debt could strain liquidity and increase financial instability. Each factor has the potential to pressure earnings or compress the stock's valuation multiple.
Analyst consensus estimates BUD will report consensus revenue of $123.1B (+2.7% year-over-year) and EPS of $6.41 (+1.6% year-over-year) for the upcoming fiscal year. The following year, analysts project $124.4B in revenue.
Anheuser-Busch InBev SA/NV is expected to report its next earnings on approximately 2026-07-30. Consensus expects EPS of $1.13 and revenue of $16.4B. Over recent quarters, BUD has beaten EPS estimates 92% of the time.
Anheuser-Busch InBev SA/NV (BUD) generated $32.2B in free cash flow over the trailing twelve months — a free cash flow margin of 26.9%. BUD returns capital to shareholders through dividends (1.6% yield) and share repurchases ($937M TTM).